Intellia Therapeutics Inc [NASDAQ: NTLA] stock went on a downward path that fall over -6.45% on Thursday, amounting to a one-week price decrease of less than -5.64%.
Over the last 12 months, NTLA stock dropped by -68.21%. The one-year Intellia Therapeutics Inc stock forecast points to a potential upside of 79.55. The average equity rating for NTLA stock is currently 1.69, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $900.60 million, with 102.03 million shares outstanding and 97.42 million shares in the current float. Compared to the average trading volume of 3.14M shares, NTLA stock reached a trading volume of 3588649 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Intellia Therapeutics Inc [NTLA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NTLA shares is $42.54 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NTLA stock is a recommendation set at 1.69. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Intellia Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 05, 2025. While these analysts kept the previous recommendation, JP Morgan dropped their target price from $45 to $13. The new note on the price target was released on February 28, 2025, representing the official price target for Intellia Therapeutics Inc stock. Previously, the target price had yet another raise to $9, while Goldman analysts kept a Sell rating on NTLA stock. On January 27, 2025, analysts decreased their price target for NTLA shares from 56 to 11.
The Average True Range (ATR) for Intellia Therapeutics Inc is set at 0.84, with the Price to Sales ratio for NTLA stock in the period of the last 12 months amounting to 15.56. The Price to Book ratio for the last quarter was 1.02, with the Price to Cash per share for the same quarter was set at 5.81.
NTLA Stock Performance Analysis:
Intellia Therapeutics Inc [NTLA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.64. With this latest performance, NTLA shares dropped by -29.15% in over the last four-week period, additionally sinking by -61.42% over the last 6 months – not to mention a drop of -68.21% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NTLA stock in for the last two-week period is set at 38.77, with the RSI for the last a single of trading hit 35.65, and the three-weeks RSI is set at 40.30 for Intellia Therapeutics Inc [NTLA]. The present Moving Average for the last 50 days of trading for this stock 10.20, while it was recorded at 9.18 for the last single week of trading, and 17.38 for the last 200 days.
Insight into Intellia Therapeutics Inc Fundamentals:
Intellia Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.77 and a Current Ratio set at 5.77.
NTLA Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NTLA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Intellia Therapeutics Inc go to 25.47%.
Intellia Therapeutics Inc [NTLA] Institutonal Ownership Details
There are presently around $91.72%, or 96.60%% of NTLA stock, in the hands of institutional investors. The top three institutional holders of NTLA stocks are: ARK INVESTMENT MANAGEMENT LLC with ownership of 11.6 million shares, which is approximately 11.9575%. BLACKROCK INC., holding 9.6 million shares of the stock with an approximate value of $$214.79 million in NTLA stocks shares; and BLACKROCK INC., currently with $$203.66 million in NTLA stock with ownership which is approximately 9.5287%.
